A phase II trial of lapatinib and capecitabine for patients with refractory advanced colorectal adenocarcinoma (LAP109859).
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Capecitabine; Lapatinib
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 May 2010 Actual patient number (29) added as reported by ClinicalTrials.gov.
- 21 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.